🙌 新登場: 你唯一需要的股票篩選器立即開始

Zealand Pharma (ZELA)

哥本哈根
貨幣 DKK
免責聲明
768.50
-15.00(-1.91%)
關閉

ZELA損益表

進階損益表
結束日期:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
總營收
aa.aaaa.aaaa.aaaa.aaaa.aa41.33192108.55103.99342.79
總營收增長
aa.aaaa.aaaa.aaaa.aaaa.aa+8.84%+364.52%-43.47%-4.2%+229.65%
營收成本
aa.aaaa.aaaa.aaaa.aaaa.aa0.42-10.97614.04688.1
毛利
aa.aaaa.aaaa.aaaa.aaaa.aa40.9219297.58-510.06-345.31
毛利增長
aa.aaaa.aaaa.aaaa.aaaa.aa+18.19%+369.23%-49.18%-622.73%+32.3%
毛利率%
aa.aaaa.aaaa.aaaa.aaaa.aa99%100%89.89%-490.51%-100.74%
其他營業費用—總計
aa.aaaa.aaaa.aaaa.aaaa.aa628.86818.24879.72306.54215.93
其他營業費用—總增長
研發費用
銷售、一般、行政費用
其他營業費用
aa.aaaa.aaaa.aaaa.aaaa.aa+30.7%+30.11%+7.51%-65.15%-29.56%
aa.aaaa.aaaa.aaaa.aaaa.aa561.42595.85581.51--
aa.aaaa.aaaa.aaaa.aaaa.aa67.88222.39298.21258.27215.93
aa.aaaa.aaaa.aaaa.aaaa.aa-0.44--48.27-
營業收入
aa.aaaa.aaaa.aaaa.aaaa.aa-587.94-626.24-782.14-816.6-561.24
營業收入增長
aa.aaaa.aaaa.aaaa.aaaa.aa-31.67%-6.51%-24.9%-4.41%+31.27%
EBIT利潤率%
aa.aaaa.aaaa.aaaa.aaaa.aa-1,422.45%-326.16%-720.56%-785.3%-163.73%
淨利息費用
aa.aaaa.aaaa.aaaa.aaaa.aa3.09-47.29-4.05-51.2519.49
淨利息費用增長
aa.aaaa.aaaa.aaaa.aaaa.aa+110.97%-1,632.47%+91.44%-1,166.37%+138.04%
利息費用—總計
aa.aaaa.aaaa.aaaa.aaaa.aa-3.21-49.31-4.09-57.79-25.83
利息和投資收入
aa.aaaa.aaaa.aaaa.aaaa.aa6.292.020.046.5445.32
其他非營業開支—總計
aa.aaaa.aaaa.aaaa.aaaa.aa5.33-33.0536.61-11.7
EBT(不含不尋常項目)
aa.aaaa.aaaa.aaaa.aaaa.aa-579.52-673.53-753.14-831.24-553.44
出售資產損益
aa.aaaa.aaaa.aaaa.aaaa.aa-----
其他不尋常項目—總計
aa.aaaa.aaaa.aaaa.aaaa.aa---2.17-124.04-146.59
EBT(含不尋常項目)
aa.aaaa.aaaa.aaaa.aaaa.aa-576.68-673.53-758.89-972.04-708.87
EBT(含不尋常項目)增長
aa.aaaa.aaaa.aaaa.aaaa.aa-192.26%-16.79%-12.67%-28.09%+27.07%
EBT(含不尋常項目)利潤率
aa.aaaa.aaaa.aaaa.aaaa.aa-1,395.2%-350.79%-699.14%-934.78%-206.79%
所得稅費用
aa.aaaa.aaaa.aaaa.aaaa.aa-5.14-4.81-3.95-6.43-5.13
企業淨收入
aa.aaaa.aaaa.aaaa.aaaa.aa-571.54-846.73-1,018.15-1,202.14-703.74
少數股權
aa.aaaa.aaaa.aaaa.aaaa.aa-----
淨收入
aa.aaaa.aaaa.aaaa.aaaa.aa-571.54-846.73-1,018.15-1,202.14-703.74
淨收入增長
aa.aaaa.aaaa.aaaa.aaaa.aa-198.32%-48.15%-20.24%-18.07%+41.46%
淨收入率%
aa.aaaa.aaaa.aaaa.aaaa.aa-1,382.77%-441%-937.99%-1,156.05%-205.3%
優先股及其他調整
aa.aaaa.aaaa.aaaa.aaaa.aa-----
普通股淨收入(不含特別項目)
aa.aaaa.aaaa.aaaa.aaaa.aa-571.54-668.71-754.94-965.61-703.74
基本每股收益—持續營運
aa.aaaa.aaaa.aaaa.aaaa.aa-16.91-17.43-17.61-20.9-12.44
基本每股收益—持續營運增長
aa.aaaa.aaaa.aaaa.aaaa.aa-189.27%-3.07%-1.04%-18.68%+40.5%
稀釋後每股收益—持續營運
aa.aaaa.aaaa.aaaa.aaaa.aa-16.91-17.43-17.61-20.9-12.44
稀釋後每股收益—持續營運增長
aa.aaaa.aaaa.aaaa.aaaa.aa-189.28%-3.06%-1.04%-18.68%+40.5%
基本加權平均流通在外股數
aa.aaaa.aaaa.aaaa.aaaa.aa33.838.3742.8746.256.59
稀釋後加權平均流通在外股數
aa.aaaa.aa